Am I an Appropriate Patient for SPRAVATO®?
If two or more antidepressants haven’t worked for you, you may have treatment-resistant depression. SPRAVATO® may be the treatment option you’ve been looking for.
Talk to Your Doctor About SPRAVATO® Today
Consider including the following questions when speaking to your healthcare provider about SPRAVATO®:
The following topics may be helpful to include when speaking with your healthcare provider about SPRAVATO®.
It’s important to remember that your treatment journey is unique and the information needed along the way may vary from person to person.
There is a study that suggests after the third oral antidepressant, remission rates dropped below 14%. If you’ve tried two or more oral antidepressants and are still experiencing depressive symptoms, you may have treatment-resistant depression and it may be time for something different.
Treatment-resistant depression is defined as not responding to two or more antidepressants of adequate dose and duration. If your doctor has diagnosed you with treatment-resistant depression, you may benefit from treatment with a different kind of medication.
It is helpful to understand the clinical trials for any medication you consider taking.
It is important to understand the potential side effects of any medication you consider taking. To help ensure safety, SPRAVATO® is available only through a restricted distribution program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program.
SPRAVATO® is only available at certified treatment centers and must be self-administered under the supervision of a healthcare provider.
Cost can sometimes impact a patient’s treatment journey; however, there may be affordability programs available to help eligible patients.
Click below to download the full Patient Discussion Guide for more information on the SPRAVATO® treatment experience